DermTech

DermTech, Inc. is a molecular diagnostic company based in La Jolla, California, focused on developing and marketing non-invasive diagnostic tests for skin cancer and related conditions. The company offers the Pigmented Lesion Assay (PLA), a gene expression test designed to help rule out melanoma and eliminate the need for surgical biopsies of atypical pigmented lesions. Additionally, DermTech provides the Nevome test as an adjunctive reflex test for the PLA, along with adhesive skin sample collection kits. The company's assays analyze multiple gene targets to assess RNA expression, utilizing a non-invasive adhesive tape biopsy method. DermTech is also engaged in developing diagnostic products for non-melanoma skin cancer and risk assessment. Its products primarily cater to pathology and oncology practitioners, with services provided through a CLIA-certified laboratory in San Diego.